Bravecto TriUNO Chewable Tablets for Dogs
£25.99 GBP
Bravecto TriUNO Chewable Tablets for Dogs
5 Star Google Customer Reviews
£25.99 GBP
Taxes included in the price
Couldn't load pickup availability
Bravecto TriUNO chewable tablets for dogs contain Fluralaner, Moxidectin, Pyrantel Embonate and are used for:
- For dogs with, or at risk from, mixed parasitic infestations by ticks or fleas, gastrointestinal nematodes, lungworm and/or heartworm. The veterinary medicinal product is exclusively indicated when use against ticks or fleas, one or more of the target gastrointestinal nematodes, prevention of either heartworm or lungworm disease (angiostrongylosis), and treatment of Angiostrongylus vasorum are all indicated at the same time.
- For the treatment of tick and flea infestations in dogs providing immediate and persistent flea (Ctenocephalides felis and C. canis) and tick (Dermacentor reticulatus, Ixodes hexagonus, I. ricinus, and Rhipicephalus sanguineus) killing activity for 1 month.
- The veterinary medicinal product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).
- For reduction of the risk of infection with Babesia canis canis via transmission by D. reticulatus for 1 month. The effect is indirect due to the veterinary medicinal product’s activity against the vector.
- For reduction of the risk of infection with Dipylidium caninum via transmission by C. felis for 1 month. The effect is indirect due to the veterinary medicinal product’s activity against the vector.
- Treatment of infections with gastrointestinal nematodes of the following species: roundworms (adult stages of Toxocara canis and Toxascaris leonina), hookworms (L4, immature adult (L5) and adult stages of Ancylostoma caninum and adult stages of Uncinaria stenocephala).
- Prevention of heartworm disease (caused by Dirofilaria immitis).
- Prevention of angiostrongylosis (by reduction of the level of infection with immature adult (L5) and adult stages of Angiostrongylus vasorum).
- Treatment of infections with Angiostrongylus vasorum (the causative agent of angiostrongylosis).
Contraindications:
Do not use in cases of hypersensitivity to the active substances or to any of the excipients.
Use during pregnancy or lactation
The safety of the veterinary medicinal product has not been established during pregnancy and lactation or in dogs intended for breeding.
Pregnancy and lactation:
The use is not recommended during pregnancy and lactation.
Laboratory studies with moxidectin in rats and mice have shown evidence of foetotoxic and teratogenic effects.
Fertility:
The use is not recommended in breeding animals.
For more information, please use the following link: https://www.noahcompendium.co.uk/?id=-488425
